Table 1

Anti-melanoma TILs used in this study

Cells% CD8% CD4% Transf.
TIL219217998
TIL5269.630.499
TIL1499.10.8598
TIL21351.548.598
TIL8670.229.898
  • Shown are the TILs CD8/CD4 composition and mRNA transfection efficiency. All TILs are HLA-A2+ and are responsive to HLA-A2+ melanomas.

  • TILs, tumor-infiltrating lymphocytes.